AnaptysBio, Inc. (LON:0HFQ)
48.64
-1.05 (-2.11%)
At close: Jan 15, 2026
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of 957.61 million as of January 16, 2026. Its market cap has increased by 197.89% in one year.
Market Cap
957.61M
Enterprise Value
1.03B
Revenue
126.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.64
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from 245.54M to 957.61M, an increase of 290.01%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 957.61M | -3.98% |
| Dec 31, 2025 | 997.36M | 209.93% |
| Dec 31, 2024 | 321.81M | -27.99% |
| Dec 29, 2023 | 446.90M | -38.89% |
| Dec 30, 2022 | 731.27M | 3.07% |
| Dec 31, 2021 | 709.46M | 64.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.53B |
| HSBC Holdings | 212.07B |
| Shell | 156.67B |
| Rio Tinto Group | 108.50B |
| Rolls-Royce Holdings | 106.47B |
| Unilever | 105.85B |
| British American Tobacco p.l.c. | 94.21B |
| GSK plc | 75.45B |